Oncopeptides
Pre-clinicalOncopeptides is a global biotech company focusing on research, development and commercialization of targeted therapies for difficult-to-treat hematological diseases.
Founded
2000
Focus
Small Molecules
About
Oncopeptides is a global biotech company focusing on research, development and commercialization of targeted therapies for difficult-to-treat hematological diseases.
Funding History
3Total raised: $115M
IPO$60MUndisclosedJun 15, 2017
Series B$40MHealthCapMar 15, 2017
Series A$15MHealthCapMay 15, 2015
Company Info
TypePrivate
Founded2000
LocationStockholm, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile